Everything has been outsourced in pharmaceuticals already. That’s not new. You can just do a quick search for CROs and CDMOs (contract research/development/manufacturing organization). Fujifilm is one. What is new is mRNA technology.
The problem is all the protocols and procedures are either developed prior if they’re novel, or they’ve been used for decades (like formulating an api into a tablet or capsule). It takes significant time no matter the resources to work out the kinks. This never happened. Something is off.
Everything has been outsourced in pharmaceuticals already. That’s not new. You can just do a quick search for CROs and CDMOs (contract research/development/manufacturing organization). Fujifilm is one. What is new is mRNA technology.
The problem is all the protocols and procedures are either developed prior if they’re novel, or they’ve been used for decades (like formulating an api into a tablet or capsule). It takes significant time no matter the resources to work out the kinks. This never happened. Something is off.